Clinical trial
Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched…
NCT00350181 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00350181 |
|---|---|
| Title | Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT |
| Official title | Sirolimus and Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor Hematopoietic Cell Transplantation |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases, Acute GVHD |
| Intervention type | Drug |
| Interventions | Sirolimus, MMF, BCNU, VP-16, CY, FTBI, BU |
| Enrollment | 11 |
| Start date | Aug 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Apr 1, 2010 |
| First posted | Jul 10, 2006 |
| Last update posted | Sep 23, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: